Correlation Engine 2.0
Clear Search sequence regions

  • child (2)
  • congenital adrenal hyperplasia (2)
  • CYP17A1 (1)
  • CYP19A1 (4)
  • CYP21A2 (1)
  • CYP2C19 (1)
  • CYP2C9 (1)
  • CYP3A4 (1)
  • female (1)
  • humans (1)
  • mother (1)
  • mtt (1)
  • NADPH (1)
  • ovaries (1)
  • patient (2)
  • POR (10)
  • prognosis (1)
  • protein human (1)
  • sex (1)
  • spain (1)
  • steroid (1)
  • uterus (1)
  • Sizes of these terms reflect their relevance to your search.

    Mutations in cytochrome P450 oxidoreductase (POR) cause a form of congenital adrenal hyperplasia (CAH). We report a novel R550W mutation in POR identified in a 46,XX patient with signs of aromatase deficiency. Analysis of aromatase deficiency from the R550W mutation in POR. Both the child and the mother had signs of virilization. Ultrasound revealed the presence of uterus and ovaries. No defects in CYP19A1 were found, but further analysis with a targeted Disorders of Sexual Development NGS panel (DSDSeq.V1, 111 genes) on a NextSeq (Illumina) platform in Madrid and Barcelona, Spain, revealed compound heterozygous mutations c.73_74delCT/p.L25FfsTer93 and c.1648C > T/p.R550W in POR. Wild-type and R550W POR were produced as recombinant proteins and tested with multiple cytochrome P450 enzymes at University Children's Hospital, Bern, Switzerland. POR-R550W showed 41% of the WT activity in cytochrome c and 7.7% activity for reduction of MTT. Assays of CYP19A1 showed a severe loss of activity, and CYP17A1 as well as CYP21A2 activities were also lost by more than 95%. Loss of CYP2C9, CYP2C19, and CYP3A4 activities was observed for the R550W-POR. Predicted adverse effect on aromatase activity as well as a reduction in binding of NADPH was confirmed. Pathological effects due to POR-R550W were identified, expanding the knowledge of molecular pathways associated with aromatase deficiency. Screening of the POR gene may provide a diagnosis in CAH without defects in genes for steroid metabolizing enzymes. © Endocrine Society 2020. All rights reserved. For permissions, please e-mail:


    Shaheena Parween, Mónica Fernández-Cancio, Sara Benito-Sanz, Núria Camats, Maria Natalia Rojas Velazquez, Juan-Pedro López-Siguero, Sameer S Udhane, Norio Kagawa, Christa E Flück, Laura Audí, Amit V Pandey. Molecular Basis of CYP19A1 Deficiency in a 46,XX Patient With R550W Mutation in POR: Expanding the PORD Phenotype. The Journal of clinical endocrinology and metabolism. 2020 Apr 01;105(4)

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 32060549

    View Full Text